Discover 1,955 paid clinical trials in Denton, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,955
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
for
Plaque Psoriasis
Location: Arlington TX, Dallas TX, Oklahoma City OK, Cypress TX,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 40+
Code: NCT07116967
Phase 3, Recruiting
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)
for
Primary Membranous Nephropathy
Location: Dallas TX, League City TX, Huntsville AL, Nashville TN,
Sponsor: Biogen
Sex: All
Age: 18 - 70+
Code: NCT06962800
Phase 3, Recruiting
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
for
Immunoglobulin A Nephropathy (IgAN)
Location: Dallas TX, Katy TX, Houston TX, Little Rock AR,
Sponsor: Biogen
Sex: All
Age: 18+
Code: NCT06935357
Phase 3, Recruiting
Phoenix Thera-Lase for Treating Chronic Pain in Patients Taking Opioid on a PRN Basis
for
Pain
Location: Dallas TX
Sponsor: Phoenix Thera-lase Systems, LLC
Sex: All
Age: 25 - 65
Code: NCT02964000
Recruiting
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Comparing the Extent to Which Maridebart Cafraglutide is Made Available in the Body of Participants Living With Overweight or Obesity After Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA)
for
Obesity, Overweight
Location: Dallas TX, Knoxville TN, Lexington KY, Madison WI,
Sponsor: Amgen
Sex: All
Age: 18 - 70
Code: NCT07908316
Phase 1, Recruiting
New
A Study of Eloralintide (LY3841136) in Female Participants With Obesity or Overweight
for
Obesity, Overweight
Location: Dallas TX, Daytona Beach FL
Sponsor: Eli Lilly and Company
Sex: Female
Age: 18 - 60
Code: NCT07808060
Phase 1, Recruiting
New
A Study of LY4329090 in Participants With Obesity or Overweight Who Are Otherwise Healthy
for
Obesity, Overweight
Location: Dallas TX, Daytona Beach FL
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 65
Code: NCT07808073
Phase 1, Recruiting
New
A Trial in Healthy Participants to Assess Drug Interaction Potential of BGB-43395
for
Healthy Adult Participants
Location: Dallas TX
Sponsor: BeOne Medicines
Sex: All
Age: 18 - 65
Code: NCT07820891
Phase 1, Recruiting
A Study of LY4355756 in Healthy Participants
for
Healthy
Location: Dallas TX
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 65
Code: NCT07765498
Phase 1, Recruiting
A Trial to Compare the Pharmacokinetics of Two Presentations of Navenibart in Healthy Participants
for
Healthy Adult Participants
Location: Dallas TX, Madison WI, Daytona Beach FL
Sponsor: Astria Therapeutics, Inc.
Sex: All
Age: 18 - 55
Code: NCT07635095
Phase 1, Recruiting
A Study of LY4515100 in Healthy Participants
for
Healthy
Location: Dallas TX
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 65
Code: NCT07339722
Phase 1, Recruiting
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
for
Metastatic Colorectal Cancer (CRC)
Location: Dallas TX, Fort Worth TX, Tyler TX, Oklahoma City OK,
Sponsor: Summit Therapeutics
Sex: All
Age: 18+
Code: NCT07228832
Phase 3, Recruiting
A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia
for
Congenital Adrenal Hyperplasia,
Location: Dallas TX, Aurora CO, Atlanta GA, Rochester MN,
Sponsor: Crinetics Pharmaceuticals Inc.
Sex: All
Age: 18 - 70+
Code: NCT07144163
Phase 3, Recruiting
Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects
for
Asthma
Location: Dallas TX, Austin TX, Bellevue NE, El Paso TX,
Sponsor: Biometry Inc
Sex: All
Age: 5 - 70+
Code: NCT07228026
Recruiting
New
A Phase 3 Trial for Intravitreal Injection of 4D-150 in Adults With Diabetic Macular Edema (DME).
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
for
Geographic Atrophy, Macular Degeneration
Location: Dallas TX, Willow Park TX, Austin TX, The Woodlands TX,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 60+
Code: NCT06635148
Phase 2, Phase 3, Recruiting
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration